Shares of InMode Ltd. (NASDAQ:INMD) climbed 9% on Thursday after the medical technology company released preliminary third-quarter revenue figures that came in well above Wall Street forecasts, while also reaffirming its full-year outlook.
InMode reported preliminary Q3 revenue between $92.5 million and $93.0 million, topping the consensus estimate of $87.9 million, representing a beat of roughly 5%.
The company also maintained its full-year 2025 revenue guidance of $365 million to $375 million, in line with analyst expectations of $366.1 million. InMode anticipates a non-GAAP gross margin for the third quarter between 77% and 79%, underscoring its strong profitability profile.
The company, known for its innovative minimally invasive medical technologies, said it plans to publish its full Q3 financial report on Wednesday, November 5, 2025, before the Nasdaq market opens. Management will then host a conference call to review results and provide additional business updates.
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.